Goldman Sachs’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$151M Buy
1,380,114
+67,187
+5% +$9.57M 0.02% 817
2025
Q4
$218M Buy
1,312,927
+858,693
+189% +$144M 0.03% 604
2025
Q3
$88.9M Sell
454,234
-153,735
-25% -$25.3M 0.01% 1022
2025
Q2
$55M Buy
607,969
+160,140
+36% +$12.7M 0.01% 1273
2025
Q1
$26.7M Buy
447,829
+121,856
+37% +$11.3M ﹤0.01% 1752
2024
Q4
$43.2M Sell
325,973
-241,855
-43% -$22.7M 0.01% 1427
2024
Q3
$29.7M Sell
567,828
-469,846
-45% -$22.1M ﹤0.01% 1692
2024
Q2
$62.8M Buy
+1,037,674
New +$72M 0.01% 1013

Other funds holding ALAB

Goldman Sachs's ALAB Position: Q1 2026 in Review

Goldman Sachs increased its Astera Labs (ALAB) stake by 5.1% in Q1 2026, buying an estimated $9.57M and bringing the position to 1,380,114 shares worth $151M. The position accounts for 0.02% of the portfolio, ranked #817.

Goldman Sachs first reported a position in ALAB in Q2 2024 and has held it in 8 quarters since. The position peaked at $218M in Q4 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Goldman Sachs held 1,380,114 shares of Astera Labs worth $151M as of Q1 2026.
  • Goldman Sachs bought 67,187 Astera Labs shares in Q1 2026, an estimated $9.57M.
  • Astera Labs made up 0.02% of Goldman Sachs's portfolio in Q1 2026, its #817 holding.
  • Goldman Sachs first reported a position in Astera Labs in Q2 2024 and has held it in 8 quarters since.
  • Goldman Sachs's Astera Labs position peaked at $218M in Q4 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.